Ó£»¨ÊÓƵ

Skip to main content

Table 3 A. Survival rates of older gastric cancer patients at different ages in the highest gastric cancer risk area in China, 2010 to 2019. B. Survival rates of older gastric cancer patients at different pathological TNM stage in the highest gastric cancer risk area in China, 2010 to 2019

From: Trends of older gastric cancer incidence, mortality, and survival in the highest gastric cancer risk area in China: 2010–2019 and prediction to 2024

Age group

Sex

N

OS

Ìý

PFS

1-Year, % (95% Cl)

2-Year, %

(95% Cl)

3-Year, %

(95% Cl)

median survival (month)(95%CI)

Ìý

1-Year, % (95% Cl)

2-Year, %

(95% Cl)

3-Year, %

(95% Cl)

median survival (month)

A.

All

Total

3423

80.2(78.7–81.7)

61.0(59.2–62.8)

46.9(45.1–48.8)

34(32–36)

Ìý

78.7(77.2–80.2)

59.5(57.7–61.4)

45.8(44.0-47.7)

33(31–35)

Ìý

Male

2649

80.5(78.9–82.2)

60.3(58.3–62.4)

45.5(43.4–47.6)

33(31–35)

Ìý

78.9(77.2–80.7)

58.7(56.7–60.8)

44.3(42.3–46.5)

32(30–34)

Ìý

Female

744

78.9(75.9–82.2)

63.3(59.7–67.1)

51.8(48.0-55.8)

38(33–42)

Ìý

78.0(74.9–81.3)

62.2(58.6–66.1)

50.7(47.0-54.7)

37(32–40)

65–69

Total

1526

81.4(79.2–83.6)

63.1(60.5–65.9)

49.3(46.6–52.2)

36(33–39)

Ìý

79.7(77.5–82.0)

61.7(59.0-64.4)

48.3(45.6–51.2)

35(32–38)

Ìý

Male

1193

82.0(79.6–84.5)

63.1(60.1–66.2)

48.5(45.4–51.8)

35(32–39)

Ìý

80.1(77.6–82.7)

61.6(58.6–64.7)

47.6(44.6–50.9)

34(31–38)

Ìý

Female

333

79.0(74.3–84.1)

63.3(57.8–69.3)

52.3(46.7–58.7)

38(31–46)

Ìý

78.2(73.4–83.3)

62.0(56.5–68.1)

51.0(45.4–57.4)

38(30–44)

70–74

Total

986

79.8(77.1–82.6)

60.2(57.0-63.7)

45.8(42.5–49.4)

33(30–36)

Ìý

78.6(75.9–81.5)

58.4(55.1–61.8)

44.3(41.0-47.8)

32(29–35)

Ìý

Male

772

80.5(77.5–83.7)

60.6(56.9–64.5)

45.0(41.3–49.1)

33(30–36)

Ìý

79.2(76.2–82.5)

58.5(54.8–62.4)

43.4(39.7–47.4)

32(28–35)

Ìý

Female

214

77.0(71.2–83.4)

59.0(52.3–66.6)

48.5(41.8–56.4)

35(26–45)

Ìý

76.5(70.6–82.9)

57.9(51.2–65.5)

47.5(40.7–55.3)

33(26–44)

75–79

Total

554

77.6(73.8–81.5)

55.8(51.4–60.5)

41.3(37.1–46.1)

28(25–33)

Ìý

76.0(72.2–80.0)

54.5(50.1–59.2)

40.5(36.2–45.2)

27(25–32)

Ìý

Male

420

77.2(72.9–81.8)

53.2(48.2–58.8)

38.5(33.7–44.0)

26(24–30)

Ìý

76.0(71.5–80.6)

51.9(46.9–57.5)

37.4(32.6–43.0)

26(23–30)

Ìý

Female

134

78.6(71.5–86.4)

63.2(55.1–72.6)

49.6(41.3–59.5)

36(27–42)

Ìý

76.3(69.0-84.3)

59.9(53.8–66.7)

45.4(40.9–59.0)

35(27–42)

80–84

Total

269

80.8(75.8–86.1)

60.7(54.6–67.5)

46.8(40.7–53.8)

33.5(29–39)

Ìý

78.8(73.6–84.4)

65.0(58.9–71.9)

46.1(39.3–52.5)

32.5(28–38)

Ìý

Male

199

80.2(74.4–86.5)

58.1(51.1–66.1)

43.1(36.2–51.3)

32(25–32)

Ìý

77.6(71.5–84.2)

57.0(49.9–65.0)

41.8(34.9–50.0)

31(24–37)

Ìý

Female

70

82.5(73.2–92.9)

68.4(57.4–81.6)

57.8(46.3–72.2)

40(28–51)

Ìý

82.5(73.2–92.9)

68.4(57.4–81.6)

56.1(44.6–70.6)

39(28–51)

≥â¶Ä‰85

Total

88

79.5(70.7–89.3)

67.1(57.2–78.8)

54.7(44.4–67.4)

38(31–49)

Ìý

79.5(70.7–89.3)

67.1(57.2–78.8)

54.7(44.4–67.4)

38(31–49)

Ìý

Male

65

76.5(65.7–89.0)

58.8(46.8–74.0)

49.0(37.1–64.9)

36(21–45)

Ìý

76.5(65.7–89.0)

58.8(46.8–74.0)

49.0(37.1–64.9)

36(21–45)

Ìý

Female

23

86.4(73.2–100.0)

86.4(73.2–100.0)

67.9(50.8–90.7)

50(42–69)

Ìý

86.4(73.2–100.0)

86.4(73.2–100.0)

67.9(50.8–90.7)

50(42–69)

B.

pTNM I

Total

321

95.5(92.8–98.3)

89.6(85.7–93.7)

83.7(78.9–88.7)

104(-)

Ìý

95.1(92.3–98.0)

89.2(85.3–93.4)

82.9(78.0–88.0)

104(-)

Ìý

Male

239

95.7(92.6–98.9)

88.3(83.6–93.4)

80.2(74.3–86.6)

103(-)

Ìý

95.1(91.9–98.5)

87.8(82.9–93.0)

79.1(73.1–85.6)

103(-)

Ìý

Female

82

94.9(89.5–100.0)

93.2(87.0-99.9)

93.2(87.0-99.9)

105(-)

Ìý

94.9(89.5–100.0)

93.2(87.0-99.9)

93.2(87.0-99.9)

104(-)

pTNM II

Total

334

88.1(84.1–92.4)

79.2(74.2–84.6)

65.9(60.1–72.3)

60(52–84)

Ìý

86.9(82.7–91.3)

78.4(73.3–83.8)

64.7(58.8–71.1)

59(49–84)

Ìý

Male

258

86.4(81.5–91.6)

75.1(69.0-81.8)

62.0(55.2–69.6)

54(44–63)

Ìý

84.7(79.6–90.2)

74.0(67.8–80.8)

60.9(54.1–68.5)

52(42–63)

Ìý

Female

76

93.2(87.0-99.9)

91.5(84.7–98.9)

77.7(67.7–89.2)

88(-)

Ìý

93.2(87.0-99.9)

91.5(84.7–98.9)

76.0(65.8–87.8)

88(-)

pTNM III

Total

746

85.9(83.2–88.7)

63.5(59.8–67.5)

47.2(43.4–51.3)

35(31–37)

Ìý

84.0(81.1–86.9)

60.9(57.2–64.9)

45.0(41.2–49.2)

32(29–36)

Ìý

Male

599

86.0(83.1–89.0)

63.2(59.0-67.6)

46.2(42.0-50.9)

34(35–42)

Ìý

84.2(81.0-87.5)

60.6(56.4–65.1)

44.3(40.1–48.9)

32(28–36)

Ìý

Female

147

85.4(79.3–91.8)

65.0(57.1–74.0)

51.0(42.9–60.7)

37(30–37)

Ìý

83.2(76.9–90.0)

62.4(54.5–71.5)

47.9(39.9–57.6)

33(27–42)

pTNM IV

Total

128

50.9(42.3–61.3)

25.9(18.8–35.7)

15.7(10.2–24.4)

13(9–16)

Ìý

48.6(40.1–59.0)

23.9(17.1–33.4)

14.7(9.3–23.1)

32(29–36)

Ìý

Male

101

48.8(39.2–60.8)

25.0(17.3–36.2)

13.1(7.6–22.7)

12(9–17)

Ìý

45.9(36.4–57.8)

22.4(15.0-33.2)

11.8(6.6–21.1)

11(9–16)

Ìý

Female

27

58.3(41.6–81.8)

29.2(15.6–54.4)

25.0(12.5–50.0)

14(8–31)

Ìý

58.3(41.6–81.8)

29.2(15.6–54.4)

25.0(12.5–50.0)

14(8–31)